Current disease status-First occurrence of the lymphoma Posts on Medivizor
Navigation Menu

Current disease status-First occurrence of the lymphoma Posts on Medivizor

How does ABVD chemotherapy affect the fertility of female patients with Hodgkin lymphoma?

How does ABVD chemotherapy affect the fertility of female patients with Hodgkin lymphoma?

Posted by on Jun 27, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined if ABVD chemotherapy impacted fertility in female patients with Hodgkin lymphoma (HL). The authors found that ABVD reduced the levels of one of the fertility hormones and the type of fertility treatment patients opted for was not affected by ABVD. Some background Many patients with HL are young and fertility...

Read More

Which patients with diffuse large B cell lymphoma benefit most from CAR-T treatment?

Which patients with diffuse large B cell lymphoma benefit most from CAR-T treatment?

Posted by on Jun 7, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study compared the effectiveness of CAR-T treatment for patients with diffuse large B cell lymphoma (DLBCL). The authors found that while a significant number of all patients benefitted from the treatment, some patients were more likely to benefit from it than others. Some background During initial treatment for DLBCL,...

Read More

How effective and safe is high-dose chemotherapy and stem cell transplant for children with lymphoma?

Posted by on Apr 14, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study examined the effectiveness and safety of high-dose chemotherapy and stem cell transplants for children with lymphoma. The study showed that the combination treatment was very effective but that the dose may need to be adjusted for some patients. Some background Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) have very...

Read More

How effective and safe is high-dose chemotherapy and stem cell transplant for children with lymphoma?

Posted by on Apr 14, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined the effectiveness and safety of high-dose chemotherapy and stem cell transplants for children with lymphoma. The study showed that the combination treatment was very effective but that the dose may need to be adjusted for some patients. Some background Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)...

Read More

Is R-CVP safer and more effective than R-CHOP for patients with painless NHL?

Posted by on Feb 5, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of two different chemotherapy regimens for patients with indolent (painless) non-Hodgkin’s lymphoma (NHL). This study found that the R-CVP regimen was similarly effective and had fewer side effects compared to R-CHOP for these patients. Some background Chemoimmunotherapy is the...

Read More

Are prognostic scores still useful for predicting outcomes for patients with advanced Hodgkin’s lymphoma?

Posted by on Jan 8, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined if international prognostic scores (IPS) could help predict treatment outcomes for patients with advanced Hodgkin's lymphoma (HL). The authors found that the IPS system is losing its predictability as treatment strategies improve for these patients. Some background Patients with HL need to be treated...

Read More

Evaluating combined modality treatment for young adults with Hodgkin lymphoma

Posted by on Dec 7, 2019 in Hodgkin's lymphoma | 0 comments

In a nutshell This study determined the safety and effectiveness of combined modality treatment for young adults with classical Hodgkin lymphoma (cHL). This study concluded that this treatment approach was well-tolerated and effective for these patients. Some background Chemotherapy regimens for pediatric patients with cHL are different from...

Read More

Evaluating pembrolizumab for patients with primary mediastinal large B-cell lymphoma that has come back or stopped responding to treatment

Posted by on Nov 28, 2019 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of pembrolizumab (Keytruda) for patients with primary mediastinal large B-cell lymphoma (PMBCL) that has come back or stopped responding to treatment. This study concluded that pembrolizumab was safe and effective for these patients. Some background PMBCL is one rare and aggressive type...

Read More